Home › Mga Autoimmune na Sakit
Pag-aaral pangklinika para sa Mga Autoimmune na Sakit na nagre-recruit sa U.S.
77 pag-aaral para sa Mga Autoimmune na Sakit ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX21 pag-aaral
- Washington, DC19 pag-aaral
- New York City, NY19 pag-aaral
- Philadelphia, PA17 pag-aaral
- Durham, NC15 pag-aaral
- Boston, MA13 pag-aaral
- Chicago, IL13 pag-aaral
- Los Angeles, CA12 pag-aaral
- Atlanta, GA9 pag-aaral
- Dallas, TX9 pag-aaral
- Miami, FL8 pag-aaral
- Milwaukee, WI8 pag-aaral
- Cleveland, OH8 pag-aaral
- Portland, OR8 pag-aaral
- San Francisco, CA7 pag-aaral
- Orange, CA7 pag-aaral
- Seattle, WA7 pag-aaral
- Pittsburgh, PA7 pag-aaral
- Cedar Rapids, IA7 pag-aaral
- Memphis, TN6 pag-aaral
- Salt Lake City, UT6 pag-aaral
- Rochester, MN6 pag-aaral
- Louisville, KY6 pag-aaral
- Kansas City, KS6 pag-aaral
- Baltimore, MD6 pag-aaral
- Ann Arbor, MI6 pag-aaral
- Jacksonville, FL6 pag-aaral
- The Bronx, NY6 pag-aaral
- New Haven, CT5 pag-aaral
- Phoenix, AZ5 pag-aaral
- Mountain View, CA5 pag-aaral
- Orlando, FL5 pag-aaral
- Nashville, TN5 pag-aaral
- Sacramento, CA5 pag-aaral
- Aurora, CO5 pag-aaral
- San Diego, CA5 pag-aaral
- Oklahoma City, OK4 pag-aaral
- Charleston, SC4 pag-aaral
- Tampa, FL4 pag-aaral
- Denver, CO4 pag-aaral
Ayos sa estado
- Alabama5 pag-aaral
- Arizona7 pag-aaral
- Arkansas4 pag-aaral
- California28 pag-aaral
- Colorado9 pag-aaral
- Connecticut5 pag-aaral
- District of Columbia6 pag-aaral
- Florida22 pag-aaral
- Georgia11 pag-aaral
- Illinois17 pag-aaral
- Indiana4 pag-aaral
- Iowa7 pag-aaral
- Kansas7 pag-aaral
- Kentucky8 pag-aaral
- Maryland21 pag-aaral
- Massachusetts15 pag-aaral
- Michigan9 pag-aaral
- Minnesota9 pag-aaral
- Missouri7 pag-aaral
- Nebraska3 pag-aaral
- New Jersey5 pag-aaral
- New York24 pag-aaral
- North Carolina20 pag-aaral
- Ohio13 pag-aaral
- Oklahoma4 pag-aaral
- Oregon9 pag-aaral
- Pennsylvania22 pag-aaral
- South Carolina4 pag-aaral
- Tennessee10 pag-aaral
- Texas24 pag-aaral
- Utah7 pag-aaral
- Virginia7 pag-aaral
- Washington8 pag-aaral
- Wisconsin8 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07039916RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Nagre-recruitPhase 2/3
Edad 6 hanggang 75 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07103746Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Nagre-recruitPhase 2
Edad 4 hanggang 69 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04339777Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 99 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00001350Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04751396Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03816345Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Nagre-recruitObservasyonal na pag-aaral
1 Month – 100 Years · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00246857Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00867269A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06056297Natural History of Bronchiectasis
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 5 hanggang 100 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00943514Secukinumab Open Label Roll-over Extension Protocol
Nagre-recruitPhase 4
Edad 6 hanggang 100 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT04638647Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT04097561Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07621809Study of PTC844 in Participants With Active Rheumatoid Arthritis
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07779616Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 4 hanggang 75 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT02579967A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06722235A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07902817Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06434363A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Nagre-recruitPhase 1
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07085104NIAID Centralized Sequencing Protocol
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
1 Day – 100 Years · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT03206099A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
Nagre-recruitPhase 2
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07541287A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06948318Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Nagre-recruitPhase 2
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT00977977Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07885605Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.